menu
    • menu
    [{"orgOrder":0,"company":"Polymun Scientific Immunbiologische Forschung GmbH","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"AUSTRIA","productType":"Hormone","year":"2010","type":"Inapplicable","leadProduct":"Afolia","moa":"FSHR","graph1":"Undisclosed","graph2":"Phase I","graph3":"Polymun Scientific Immunbiologische Forschung GmbH","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Injection","sponsorNew":"Polymun Scientific Immunbiologische Forschung GmbH \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"Polymun Scientific Immunbiologische Forschung GmbH \/ Undisclosed"},{"orgOrder":0,"company":"Polymun Scientific Immunbiologische Forschung GmbH","sponsor":"Polymun Scientific Immunbiologische Forschung GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SPAIN","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"763SIP8","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Polymun Scientific Immunbiologische Forschung GmbH","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Polymun Scientific Immunbiologische Forschung GmbH \/ Polymun Scientific Immunbiologische Forschung GmbH","highestDevelopmentStatusID":"6","companyTruncated":"Polymun Scientific Immunbiologische Forschung GmbH \/ Polymun Scientific Immunbiologische Forschung GmbH"},{"orgOrder":0,"company":"Polymun Scientific Immunbiologische Forschung GmbH","sponsor":"IAVI","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"MOS1SIP","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Polymun Scientific Immunbiologische Forschung GmbH","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Polymun Scientific Immunbiologische Forschung GmbH \/ Polymun Scientific Immunbiologische Forschung GmbH","highestDevelopmentStatusID":"6","companyTruncated":"Polymun Scientific Immunbiologische Forschung GmbH \/ Polymun Scientific Immunbiologische Forschung GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals by Polymun Scientific Immunbiologische Forschung GmbH

    Menu

    Polymun Scientific Immunbiologische Forschung GmbH

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : MOS1SIP,MOS2SIP,M3SIP8,MPLA-5

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I

                            Recipient : IAVI

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living with HIV (PLWH) in Africa

                            Details : MOS1SIP is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of HIV Infections.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            June 07, 2024

                            Lead Product(s) : MOS1SIP,MOS2SIP,M3SIP8,MPLA-5

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I

                            Recipient : IAVI

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : 763SIP8,MPLA-5

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Recipient : Fundació Clínic per a la Recerca Biomèdica

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 ...

                            Details : 763SIP8 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            March 16, 2023

                            Lead Product(s) : 763SIP8,MPLA-5

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Recipient : Fundació Clínic per a la Recerca Biomèdica

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed

                            Polymun Scientific Immunbiologische Forschung GmbH

                            Austria arrow
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Afolia

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous Application

                            Details : Afolia is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Hormone

                            Upfront Cash : Inapplicable

                            June 10, 2010

                            Lead Product(s) : Afolia

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.